FDA to Discuss Human Factors in Medical Device Submissions at Town Hall

The U.S. Food and Drug Administration is scheduled to host a Town Hall today to discuss its final guidance regarding human factors information in medical device marketing submissions. This initiative aims to establish a risk-based framework for both manufacturers and FDA staff, ensuring the safe and effective use of medical devices. The guidance is crucial for improving patient safety and device usability.